A new cyclodepsipeptide, designated roseocardin, was isolated from the culture broth of Trichothecium roseum TT103. Roseotoxin B and destruxins A and B were also isolated during the same procedure. The structure of roseocardin was determined by EI-MS, NMRand X-ray crystallographic analysis. Roseocardin as well as the other cyclodepsipeptides were shown to produce positive inotropic effects on rat heart muscles.
There have been only a few reports in the literature of cardiotonic compounds isolated from microorganisms. The mycelial extract of Cordyceps sinensis has a cardiotonic effect on the right atrium of rats.1'2* However, this effect is not potent enough for the main ingredients to be purified. A substantial cardiac stimulant effect has been found in the culture broth of Trichothecium roseum TT103. A new cyclodepsipeptide, roseocardin, as well as roseotoxin B, and destruxins A and B, have been found to possess a cardiotonic action.
The structural characteristics of the compounds are unique, differing greatly from those of other known cardiotonic agents. In the present study, we describe the isolation, structural determination and biological activity of roseocardin.
Materials and Methods Fermentation
The strain TT103is from our stock cultures which have been collected from various regions of Japan. Spores (2.3 x 105) of the fungi were inoculated into a culture medium (1.5 liters) and cultured at 25°C for 4 days. The medium contained 2 g of yeast extract (DIFCO) and 20 g of molt extract (OXOID) per liter. The pH of the medium was adjusted to 5.5 with cone. HC1.
Isolation
The pooled broth (15 liters) was incubated with 3 liters of HP-20 resin (Mitsubishi Kasei Corporation).
The resin was washed with water and then eluted with MeOH. The MeOH was removed in vacuo leaving a brown solid (12.6g). The crude material was dissolved in 400ml of 1007 water and the solution acidified to pH 3.0 with cone. HC1. The solution was extracted three times with the same volume of EtOAc. Evaporation of the solvent gave 1.0g of a crude residue. The residue was applied to a silica gel column of 50g ( Wakogel C-300, Wako) and washed with EtOAc-hexane, 1 : 1 (v/v) flections was collected. The structure was solved by the direct method using a MULTAN78 and the Monte Carlo method. The maximumand minimumpeaks on the final difference Fourier map corresponded to 0.25 and -0.14 sX~3, respectively. All calculations were performed using UNICS-lIl program system software.
Examination of Effects on Heart Muscles
Male rats of the Sprague-Dawley strain (200-400 g) were decapitated, and the right atria isolated. The preparation was mounted in a horizontal bath of 0.8ml and per fused at a rate of 3.5-4.0ml/minute with a salt solution of the following composition (mM): NaCl, 140; KC1, 5; CaCl2, 2.6; MgCl2, 1.3; HEPES, 5; and glucose, 10, as reported previously1>2). The per fusion solution was aerated. The pH of the solution was 7.3-7.4. The dissected right atria exhibited automatic contractions. Contractions were recorded isometrically through a strain gauge transducer Physioteck, Tokyo) connected to the preparation. It was examinedwhether the isolated compounds affected the contraction force (inotropy) and the intercontraction interval (chronotropy).
Results

Isolation
The crude active fractions eluted from the silica gel DEC. 1997 column were separated by HPLCon a Capcellpack C18 column. Four active fractions (I, II, III and IV) which are marked by arrows in Fig. 1 were collected. The acetonitrile in fractions was removed by evaporation. The active compoundswere extracted with EtOAcfrom the aqueous solutions. Evaporation of the solvent gave compounds I, II, III and IV in amounts of 12.4, 86.3, 21.0 and 46.1 mg, respectively.
The structure of compound IV is shown in Fig. 2 .
Structural Determination of CompoundIV
The 13C NMR, XH NMR, TOCSY, HMQC, HMBC and NOESY spectra of the compoundIV were measured in CDC13. Analyses by 13C NMRand HREI-MS indicated a molecular formula ofC31H53N5O7. All proton and carbon signals were assigned as listed in Table 1 . The *H NMRspectrum ofIV is shown in Fig. 3 . The sequence of the components was determined by HMBC and NOESYexperiments as shown in Fig. 4 . The HMBCcorrelations were observed between H-l and 31-C, between the NHof He and 31-C, between H-7 and 6-C, between H-8 and 6-C, between H-l3 and 12-C, between H-l4 and 12-C, between the NH of j8-Ala and 16-C, and between H-20 and 19-C. Furthermore, NOESYcorrelations were observed between the NHof He and H-2, between the NHof He and H-26, between the NH of , between H-14 and the NH of /?-Ala, between the NH of j8-Ala and H-l7, between the NHof j}-Ala and H-l8, and between H-20 and H-26. From these results, the structure of compound IV was determined as shown in Relative Stereochemistry of Roseocardin (IV) To confirm the proposed structure ofroseocardin (IV), X-ray crystallographic analysis was performed. The relative stereochemistry of IV was determined as shown in Fig. 5 . The crystal data are summarized in Table 3 .
Absolute Stereochemistry of Roseocardin (IV)
The absolute configuration of the amino acid residues in IV was determined. The complete acid hydrolysates ofIV were coupled with ( + )-l-(9-fluorenyl) ethyl chloroformate and analyzed by column chromatography. The results indicated that the complete acid hydrolysates of IV contained i^Ile and L-MeVal. Thus, the absolute structure of IV was determined to be cyclo
Structure Elucidation of Other Compounds
The structures of the other active compounds were also determined by 13C NMR, XH NMR, TOGSY and HMQG. The NMRchemical shifts are listed in Table 4 . These spectra were similar to those ofroseocardin. SI-MS of compounds I and III displayed molecular ions at m/z 578.4 (M+H+) and 594.1 (M+H+), respectively. The HREI-MSof compound II displayed molecular ion at m/z 591.1. By theassignment of protons and carbons, the compounds I, II and III were identified as destruxin A,roseotoxinB and destruxin B (Fig. 6) ,respectively. Thesecompounds have previouslybeen isolated from Trichothecium roseum3A) and Metarhizium anisopliae.5~8)
Inotropic and ChronotropicEffects onHeartMuscles Biologicalactivities of roseocardin onautomatically contracting right atria were examined to determine whetherthe compound had an inotropic effect to increase the contractileforceof a right atrium, and whetherit had a chronotropic effect to change the intercontraction interval.Assummarized in Table 5 , roseocardin In the present study we have shown that the newly isolated roseocardin as well as three related cyclodepsipeptides display positive inotropic and negative chronotropic effects on mammalianhearts. This discovery could result in the development of a class of cardiotonic agent since these compoundsare structurally unrelated to the cardiac stimulants in current use.
